RPS24 Microexon Isoform As a Novel Biomarker for Estrogen Receptor-Positive Breast Cancer Progression and Therapeutic Resistance

The authors identified notable variations in ribosomal protein S24 (RPS24) splicing patterns across breast cancer subtypes and investigated this novel regulatory mechanism.